Dosimetry and optimal scan time of [18F]SiTATE-PET/CT in patients with neuroendocrine tumours

Volume: 48, Issue: 11, Pages: 3571 - 3581
Published: Apr 29, 2021
Abstract
Radiolabelled somatostatin analogues targeting somatostatin receptors (SSR) are well established for combined positron emission tomography/computer tomography (PET/CT) imaging of neuroendocrine tumours (NET). [18F]SiTATE has recently been introduced showing high image quality, promising clinical performance and improved logistics compared to the clinical reference standard 68Ga-DOTA-TOC. Here we present the first dosimetry and optimal scan time...
Paper Details
Title
Dosimetry and optimal scan time of [18F]SiTATE-PET/CT in patients with neuroendocrine tumours
Published Date
Apr 29, 2021
Volume
48
Issue
11
Pages
3571 - 3581
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.